HemOnc Today Current Issue
The following articles appeared in the print edition of HemOnc Today.
Table of Contents
- New-onset diabetes provides ‘window of opportunity’ for early pancreatic cancer detection Ryan Lawrence; Regina Schaffer
-
- Maintaining wellness as an oncologist: Balancing self-care, recognizing distractions Talitha Bennett
- AACR Cancer Progress Report highlights research breakthroughs, aims for increased funding Ryan Lawrence
- Cancer drug trials too slow, patients and families say in survey Jennifer Byrne
- ‘Broken’ system: Labels, guidelines include cancer drugs that failed confirmatory trials Ryan Lawrence
- 2-year data confirm benefit of nivolumab regimen for advanced gastric, esophageal cancers Jennifer R. Southall
- Abiraterone acetate plus prednisolone ‘new standard of care’ in prostate cancer subset Ryan Lawrence
- Ablative MRI-guided radiation therapy extends survival in inoperable pancreatic cancer Jennifer R. Southall
- Black patients less likely to meet eligibility criteria for pancreatic cancer trials Ryan Lawrence
-
- Lung cancer trial enrollment dropped 43% amid COVID-19 pandemic Mark Leiser
- Nasopharyngeal cancer incidence varies among Asian American subgroups Jennifer R. Southall
- Ribociclib regimen extends OS in advanced breast cancer Jennifer R. Southall
- ‘Science of trustworthiness’ key to reducing cancer disparities Devin McLaughlin